← Back to Clinical Trials
Recruiting NCT06496386

NCT06496386 Robotic Assisted Major Lung Resection in Elderly Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06496386
Status Recruiting
Phase —
Sponsor Scientific Institute San Raffaele
Condition Lung Cancer
Study Type OBSERVATIONAL
Enrollment 386 participants
Start Date 2024-09-30
Primary Completion 2025-09-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 386 participants in total. It began in 2024-09-30 with a primary completion date of 2025-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study is a retrospective observational study. The study is designed to be multicentric and it will analyze medical records from selected patients that underwent major lung resection using DaVinci surgical platform performed in the participating centers. There are no risks for the patients, as this is a retrospective data collection.

Eligibility Criteria

Inclusion Criteria: * Age \>18 years at the moment of surgery * Suspected or confirmed diagnosis of lung cancer * The patient can be candidate in terms of cardiac, kidney, liver and respiratory function the primary pathology is under control or controllable * Absence of extrapulmonary metastases that are not controlled or controllable * All procedures included use of DaVinci robot system Exclusion Criteria: * Age \< 18 years at the moment of surgery * Patients who cannot undergo surgery, as they do not meet the conditions outlined above

Contact & Investigator

Central Contact

Pierluigi Novellis, MD

✉ novellis.pierluigi@hsr.it

📞 0226437202

Frequently Asked Questions

Who can join the NCT06496386 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06496386 currently recruiting?

Yes, NCT06496386 is actively recruiting participants. Contact the research team at novellis.pierluigi@hsr.it for enrollment information.

Where is the NCT06496386 trial being conducted?

This trial is being conducted at Rozzano, Italy, Milan, Italy.

Who is sponsoring the NCT06496386 clinical trial?

NCT06496386 is sponsored by Scientific Institute San Raffaele. The trial plans to enroll 386 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology